Cargando…
Signal Enhancement in the HPLC-ESI-MS/MS analysis of spironolactone and its metabolites using HFIP and NH(4)F as eluent additives
This paper describes an LC-MS/MS method to determine the concentration of spironolactone and its metabolites 7-alpha-methylthiospironolactone and canrenone in blood plasma samples. The resulting assay is simple (using protein precipitation for sample preparation) and sensitive (the lower limit of qu...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5395588/ https://www.ncbi.nlm.nih.gov/pubmed/28224249 http://dx.doi.org/10.1007/s00216-017-0255-4 |
_version_ | 1783229893550538752 |
---|---|
author | Takkis, Kalev Aro, Rudolf Kõrgvee, Lenne-Triin Varendi, Heili Lass, Jana Herodes, Koit Kipper, Karin |
author_facet | Takkis, Kalev Aro, Rudolf Kõrgvee, Lenne-Triin Varendi, Heili Lass, Jana Herodes, Koit Kipper, Karin |
author_sort | Takkis, Kalev |
collection | PubMed |
description | This paper describes an LC-MS/MS method to determine the concentration of spironolactone and its metabolites 7-alpha-methylthiospironolactone and canrenone in blood plasma samples. The resulting assay is simple (using protein precipitation for sample preparation) and sensitive (the lower limit of quantification is close to 0.5 ng/ml) while requiring only 50 μl of plasma, making it especially suitable for analyzing samples obtained from pediatric and neonatal patients where sample sizes are limited. The sensitivity is achieved by using ammonium fluoride as an eluent additive, which in our case amplifies the signal from our analytes in the plasma solution on average about 70 times. The method is fully validated according to the European Medicines Agency’s guideline and used for the measurement of pediatric patients’ samples in clinical trials for evaluating oral spironolactone’s and its metabolites’ pharmacokinetics in children up to 2 years of age. |
format | Online Article Text |
id | pubmed-5395588 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-53955882017-05-04 Signal Enhancement in the HPLC-ESI-MS/MS analysis of spironolactone and its metabolites using HFIP and NH(4)F as eluent additives Takkis, Kalev Aro, Rudolf Kõrgvee, Lenne-Triin Varendi, Heili Lass, Jana Herodes, Koit Kipper, Karin Anal Bioanal Chem Research Paper This paper describes an LC-MS/MS method to determine the concentration of spironolactone and its metabolites 7-alpha-methylthiospironolactone and canrenone in blood plasma samples. The resulting assay is simple (using protein precipitation for sample preparation) and sensitive (the lower limit of quantification is close to 0.5 ng/ml) while requiring only 50 μl of plasma, making it especially suitable for analyzing samples obtained from pediatric and neonatal patients where sample sizes are limited. The sensitivity is achieved by using ammonium fluoride as an eluent additive, which in our case amplifies the signal from our analytes in the plasma solution on average about 70 times. The method is fully validated according to the European Medicines Agency’s guideline and used for the measurement of pediatric patients’ samples in clinical trials for evaluating oral spironolactone’s and its metabolites’ pharmacokinetics in children up to 2 years of age. Springer Berlin Heidelberg 2017-02-21 2017 /pmc/articles/PMC5395588/ /pubmed/28224249 http://dx.doi.org/10.1007/s00216-017-0255-4 Text en © The Author(s) 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Research Paper Takkis, Kalev Aro, Rudolf Kõrgvee, Lenne-Triin Varendi, Heili Lass, Jana Herodes, Koit Kipper, Karin Signal Enhancement in the HPLC-ESI-MS/MS analysis of spironolactone and its metabolites using HFIP and NH(4)F as eluent additives |
title | Signal Enhancement in the HPLC-ESI-MS/MS analysis of spironolactone and its metabolites using HFIP and NH(4)F as eluent additives |
title_full | Signal Enhancement in the HPLC-ESI-MS/MS analysis of spironolactone and its metabolites using HFIP and NH(4)F as eluent additives |
title_fullStr | Signal Enhancement in the HPLC-ESI-MS/MS analysis of spironolactone and its metabolites using HFIP and NH(4)F as eluent additives |
title_full_unstemmed | Signal Enhancement in the HPLC-ESI-MS/MS analysis of spironolactone and its metabolites using HFIP and NH(4)F as eluent additives |
title_short | Signal Enhancement in the HPLC-ESI-MS/MS analysis of spironolactone and its metabolites using HFIP and NH(4)F as eluent additives |
title_sort | signal enhancement in the hplc-esi-ms/ms analysis of spironolactone and its metabolites using hfip and nh(4)f as eluent additives |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5395588/ https://www.ncbi.nlm.nih.gov/pubmed/28224249 http://dx.doi.org/10.1007/s00216-017-0255-4 |
work_keys_str_mv | AT takkiskalev signalenhancementinthehplcesimsmsanalysisofspironolactoneanditsmetabolitesusinghfipandnh4faseluentadditives AT arorudolf signalenhancementinthehplcesimsmsanalysisofspironolactoneanditsmetabolitesusinghfipandnh4faseluentadditives AT korgveelennetriin signalenhancementinthehplcesimsmsanalysisofspironolactoneanditsmetabolitesusinghfipandnh4faseluentadditives AT varendiheili signalenhancementinthehplcesimsmsanalysisofspironolactoneanditsmetabolitesusinghfipandnh4faseluentadditives AT lassjana signalenhancementinthehplcesimsmsanalysisofspironolactoneanditsmetabolitesusinghfipandnh4faseluentadditives AT herodeskoit signalenhancementinthehplcesimsmsanalysisofspironolactoneanditsmetabolitesusinghfipandnh4faseluentadditives AT kipperkarin signalenhancementinthehplcesimsmsanalysisofspironolactoneanditsmetabolitesusinghfipandnh4faseluentadditives |